Metimyd

   
Google
 
Web NewDrugInformation.com

Metimyd


Drug - Metimyd
The trade name of the product as shown on the labeling.

Dosage - SUSPENSION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prednisolone Acetate; Sulfacetamide Sodium
Multiple ingredients are in alphabetical order.

Strength - 0.5%;10%
The potency of the active ingredient(s), Prednisolone Acetate; Sulfacetamide Sodium. May repeat for multiple part products.

Applicant - SCHERING
The firm name holding legal responsibility for Metimyd. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010210
The FDA assigned number to Metimyd. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Metimyd. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Metimyd was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Metimyd. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Metimyd is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Corp Sub Schering Plough Corp
The full name of the firm holding legal responsibility for the new application of Metimyd.

Metimyd